Table 4.
Parameter | Observations (n) | Events | Reference category | Hazard ratio | C-statistic | P value |
---|---|---|---|---|---|---|
Gender | 675 | 342 | Male | 1.78 | 0.556 | 0.00028 |
rs4293393 minor variant in phase with mUMOD | 668 | 337 | A (major) | 0.6885 | 0.507 | 0.36 |
rs4293393 minor variant in phase with wtUMOD | 494 | 221 | A (major) | 0.6152 | 0.529 | 0.064 |
rs4293393 variant (at least 1 G allele present) | 499 | 224 | 2 A alleles present | 0.6943 | 0.528 | 0.13 |
mUMOD type | 675 | 342 | p.(H177_R185del) | 0.561 | ||
Cysteine gain | 0.9234 | 0.88 | ||||
Cysteine loss | 0.9995 | 1.0 | ||||
Deletion/insertion | 0.6369 | 0.3 | ||||
Hydrophobic amino acid gain | 0.3197 | 0.066 | ||||
Proline gain | 0.5321 | 0.13 | ||||
Other | 0.6155 | 0.15 | ||||
In vitro score | 393 | 198 | 1.5457 | 0.591 | 0.0022 | |
Cysteine-rich domains | 675 | 342 | All other domains | 0.8247 | 0.521 | 0.38 |
ADTKD-UMOD, autosomal dominant tubulo-interstitial kidney disease due to UMOD mutations; mUMOD, mutant uromodulin; wtUMOD, wild-type uromodulin.
Data combine Wake Forest and International cohorts.